Peng Hu

EZH2 as a potential therapeutic target for gastrointestinal cancers.

N. Nabavi, M. Entezari, A. Taheriazam, 2023, Pathology, research and practice.

Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy

K. Hushmandi, Y. N. Ertas, Shokooh Salimimoghadam, 2023, Translational oncology.